McDermott + Bull has successfully placed Sean Rathbone as President of PNP Pharmaceuticals, a portfolio company of Gladius Partners. Based in Burnaby, British Columbia, PNP Pharmaceuticals is a unique contract manufacturer of nutraceutical and pharmaceutical products....
McDermott + Bull has successfully placed Saikiran (Sai) Chaluvadi, Ph.D. as Vice President of Research + Development, Scientific Affairs at Liquid I.V. Reporting to the CEO, Sai will drive company success by building a competitive innovation portfolio while leading...
McDermott + Bull has successfully placed Betsy Brookes as Vice President of Human Resources at RapidAI. Working closely with the Chief Executive Officer and leadership team, Betsy will be the go-to person for all strategic business-related issues with HR implications....
McDermott +Bull has successfully placed Enrico Brambilla as Vice President, Product Research and Development at Eyenovia. Reporting to the COO, Enrico will lead a team of high-performing engineers and be accountable for the design, development, and qualification of...
McDermott + Bull has successfully placed Ivan Velazquez and John Harrington as Vice President of Operations for private equity-backed Specialty Dental Brands, a Leon Capital Group portfolio company. Both Ivan and John will oversee the day-to-day operations of a...
McDermott + Bull has successfully placed Chris Robillard as the Chief Business Officer at Crinetics Pharmaceuticals. Chris will develop, lead, and execute on the company’s business development strategy. He will build global pharmaceutical alliances to maximize the...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
